Want to see ES:PRM full AI Analyst Report?
PRIM, S.A. (PRM) Stock Price & Analysis
PRM Stock Chart & Stats
- Day’s Range
- EUR 12.40 - EUR 12.45
- 52-Week Range
- EUR 12.10 - EUR 13.90
- Previous Close
- EUR 12.45
- Volume
- 376
- Average Volume (3M)
- 2,857
- Market Cap
- EUR 210.17M
- Enterprise Value
- EUR 225.13T
- Total Cash (Recent Filing)
- EUR 25.42M
- Total Debt (Recent Filing)
- EUR 14.89M
- Price to Earnings (P/E)
- 16.3
- Beta
- 0.26
- Next Earnings
- N/A
- EPS Estimate
- N/A
- Last Dividend Ex-Date
- Jul 13, 2026
- Dividend Yield
- 4.06%
Bulls Say, Bears Say
Bulls Say
Debt-free Balance Sheet
Being effectively unlevered provides durable financial flexibility: lower interest burden, more optionality for capex, dividends or bolt-on M&A, and greater resilience to cyclical shocks. Over the next 2–6 months this supports stable operations and strategic optionality.
Consistent Revenue Growth
Multi-year, steady top-line growth reflects durable product demand, recurring replacement/consumable dynamics and effective distribution into hospitals and clinics. This trend supports medium-term capacity planning and predictable revenue base for reinvestment.
Improved 2025 Profitability
Material margin recovery indicates better mix or cost control and demonstrates the business can extract operating leverage. Sustained higher margins enhance cash flow potential and ROE, underpinning durable earnings power if maintained versus prior volatility.
Bears Say
Uneven Cash Generation
Intermittent negative operating and free cash flow in prior years plus a 2025 FCF step-down versus 2024 signal that cash conversion is inconsistent. This reduces the reliability of internally funded growth and increases sensitivity to working-capital swings and capex over the medium term.
Margin Volatility
Historic swings in gross and operating margins point to exposure to input costs, product mix or pricing pressures. Persistent volatility undermines forecast accuracy and margin sustainability, raising execution risk for translating revenue growth into stable profits.
Limited Return Expansion Without Leverage
Zero debt reduces financial risk but constrains one lever for boosting ROE and EPS growth. If operating improvements or market share gains stall, the company has less scope to accelerate returns via capital structure, potentially slowing medium-term earnings growth.
PRIM, S.A. News
PRM FAQ
What was PRIM, S.A.’s price range in the past 12 months?
What is PRIM, S.A.’s market cap?
When is PRIM, S.A.’s upcoming earnings report date?
How were PRIM, S.A.’s earnings last quarter?
Is PRIM, S.A. overvalued?
Does PRIM, S.A. pay dividends?
What is PRIM, S.A.’s EPS estimate?
How many shares outstanding does PRIM, S.A. have?
What happened to PRIM, S.A.’s price movement after its last earnings report?
Which hedge fund is a major shareholder of PRIM, S.A.?
What is the TipRanks Smart Score and how is it calculated?
Company Description
PRIM, S.A.
Prim, S.A., operating through its various affiliated entities, specializes in the conception, production, and sale of orthopedic solutions. These items are utilized across diverse fields such as physical therapy, aquatic therapies (like thalassotherapy and hydrotherapy), rehabilitation, spa facilities, elderly care, and a range of supportive techniques, reaching customers within Spain and across global borders. Furthermore, the company supplies specialized goods for neuro-trauma, cardiovascular health, neuromodulation, surgical suites, endosurgical procedures, cosmetic surgery, and ear, nose, and throat (ENT) specialties. Beyond its product offerings, Prim, S.A. is involved in overseeing wellness developments, including hotel properties, vacation resorts, and athletic clubs. The firm was established in 1870 and maintains its principal office in Móstoles, Spain.
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- CEO
- Fernando Oliveros Arreaga
- Employees
- 959
- Website
- www.prim.es
- Address
- Polígono Industrial número 1, Móstoles, MA, 28938, ES
PRIM, S.A. (PRM) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 4 | 3 | 15 |
| Technical Analysis | 4 | 3 | 3 |
| Moving Averages | 0 | 0 | 12 |






